MHRA approves Novo Nordisk’s triple-strength Wegovy

Novo Nordisk And India's Emcure Have Struck A Deal For GLP-1 Semaglutide Wegovy
The approval represents “another important step” in supporting people with obesity (Shutterstock)
Molly Bowcott

Read more by Molly Bowcott

Molly Bowcott joined C+D as a digital reporter in October 2024 after graduating from a master’s in journalism at City, University of London. She previously worked as a news reporter at the U.S. Sun, covering business, politics and money.

Latest from Regulation

More from News